SouthViews No. 207, 28 September 2020
Is the right to exclusivity a Hamlet question?
By Justice Prabha Sridevan
Today the judicial authority may be faced with balancing patent rights and patients’ rights or right to life. It shall use all the tools at its command and innovate if necessary, but shall rule in favour of life.
Download the SouthViews:
This article was tagged: Access to Medicines, Affordable Medicines, Compulsory Licenses, Coronavirus, COVID-19, COVID-19 Technology Access Pool (C-TAP), Flexibilities, Generic Medicines, Genetic Resources, Health, Human Rights Council, India, Injunction, Innovation, Intellectual Property, Nagoya Protocol, Patent, Patent Pool, Pharmaceuticals, Public Health, Right to Health, Right to Life, Technology Transfer, TRIPS, Vaccines, World Health Organization (WHO)